Aspirin Resistance and Treatment Non-Compliance in Cardiovascular Patients
Author Information
Author(s): Eduard Shantsila, Gregory YH Lip
Primary Institution: Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK
Hypothesis
Is aspirin resistance or treatment non-compliance responsible for cardiovascular complications?
Conclusion
Non-compliance with aspirin treatment is a significant factor contributing to cardiovascular complications, often mistaken for aspirin resistance.
Supporting Evidence
- Up to 40% of patients with cardiovascular disease do not comply with aspirin.
- 12% of patients discontinued all medications after acute myocardial infarction.
- 28% of patients can be classified as 'aspirin resistant', but many are actually non-compliant.
Takeaway
Some people don't take their aspirin as they should, which can lead to heart problems. It's important to check if patients are really taking their medicine instead of just assuming they are resistant to it.
Potential Biases
Potential bias in self-reported compliance data.
Limitations
The article discusses the variability in defining aspirin resistance and the lack of reliable compliance measurement in studies.
Participant Demographics
Patients with cardiovascular disease, including those post-myocardial infarction.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website